You are here: Home :: Keyword index :: Bre bis com :: Clitocybe nebularis - co-operativity Clopidogrel

Items for "Clopidogrel"

Inhibition of platelet aggregation for the secondary prevention after ACS: When clopidogrel instead of ASA, when clopidogrel and ASA?

Long-term inhibition of platelet aggregation is essential for the secondary prevention after acute coronary syndromes (ACS)...

Keywords: Akutes Koronarsyndrom, Azetylsalizylsäure, Clopidogrel

01/2006 | Hämostaseologie, Schattauer

Platelet inhibitors from a cardiological viewpoint: evidence based therapy and new concepts for the acute coronary syndrome without ST-segment elevation

The pathophysiology of the acute coronary syndrome is related to a vulnerable, inflammatory plaque promoting activation and aggregation of platelets...

Keywords: Glykoprotein-IIb/IIIa-Rezeptorantagonisten, Clopidogrel, Azetylsalizylsäure, Akutes Koronarsyndrom

01/2006 | Hämostaseologie, Schattauer

Pre-treatment with clopidogrel and postprocedure troponin elevation after elective percutaneous coronary intervention

Elevated troponin after elective percutaneous coronary intervention (PCI) has been associated with a worse prognosis...

Keywords: Clopidogrel, troponin, percutaneous coronary intervention

00/0000 | Thrombosis and Haemostasis, Schattauer

Effect of antiplatelet agents clopidogrel, aspirin, and cilostazol on circulating tissue factor procoagulant activity in patients with peripheral arterial disease

Tissue factor (TF) is the physiological initiating mechanism for blood coagulation. Platelets play an important role in monocyte TF expression, thrombosis and inflammation...

Keywords: Aspirin, Clopidogrel, Tissue factor, peripheral vascular disease, platelets

12/2006 | Thrombosis and Haemostasis, Schattauer

Clopidogrel resistance

Clopidogrel as a thienopyridine is a potent antiplatelet drug blocking the P2Y₁₂ ADP receptor...

Keywords: antiaggregatorische Therapie, Clopidogrel, P2Y12-Rezeptor

10/2006 | LaboratoriumsMedizin, Walter de Gruyter